Search

ACE393

ACE393 is an injectable vaccine designed to combat the bacterium Campylobacter jejuni, one of the greatest causes of bacterial diarrhoeal infections in the developed world.

DNB-001

In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve. … DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma.

EHC18

EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.

Citrulline

Citrulline is an amino acid. It is made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle.

Atractylodes japonica root oil

It is present in some cosmetic products such as whitening creams as an active ingredient and lubricant for skin irritation.

MB-07803

It is designed to block the metabolic pathway in the liver that is responsible for producing glucose.

EDP1815

EDP1815, was investigated in several clinical trials (NCT05066373, NCT05439941, NCT05682222, NCT03733353, NCT04603027, NCT04488575, NCT05121480, NCT04393246) to evaluate its safety and efficacy in conditions

PI-0824

Currently, most doctors who treat patients with PV will prescribe high-dose steroids and drugs that suppress the immune system in an effort to decrease the production of these antibodies. … Pemphigus vulgaris (PV) is an autoimmune disease affecting approximately 40,000 people worldwide.

CY301

CY301 (Simplivir) is an investigational gene silencing compound developed by CytoGenix for the treatment of HSV.

Cadralazine